WHO Regional Committee for Europe - 65th session Vilnius, Lithuania, 14–17 September 2015

Photo: Getty Images

Developing global health sector strategies for HIV, viral hepatitis, STIs, 2016–2021

WHO Director-General, Dr Margaret Chan: “Next year, the World Health Assembly will address strategies for HIV, viral hepatitis and sexually transmitted infections .”

2 |

Three separate, yet interlinked, strategies

End the AIDS epidemic by 2030Build on momentum; accelerate (“fast-track”) the response; aligned to UNAIDS strategy

End STI epidemics as a major public health threat Neglected area; complexity; drug resistance

Eliminate viral hepatitis as a major public health threat Silent epidemic, yet emerging global interest; increasing patient demand; new prevention and treatment opportunities

FIRST

Building on previous

strategies

3 |

Frameworks for Action: SDG Framework and Universal Health Coverage (UHC); the continuum of care/services; public health approach

GHSS: Vision, Goal, Targets

Strategic Direction 2:

Interventions for impact

The “what”

Strategic Direction 4:

Financing for sustainability

The financing

Strategic Direction 1: Information for focus and

accountability

The “who” and “where”

Strategic Direction 5:

Innovation for acceleration

The future

Strategy Implementation: Leadership, Partnership, Accountability, Monitoring & Evaluation

Strategic Direction 3:

Delivering for quality and

equity

The “how”

Country Action Partner ActionWHO Action

The three dimensions of UHC

4 |

HIV Impact Targets for 2020

Prevention: • 75% reduction in new HIV infections (including key

populations), to less than 500 000 (compared to 2010); • zero new infections among infants.

Reduce HIV-related deaths: • below 500 000 (below 200 000 for 2030).

Treatment: • 90% PLHIV tested; 90% treated; 90% virally suppressed.

5 |

Viral Hepatitis Targets for 2030

Incidence:• 90% reduction in new cases of chronic HBV and HCV

infection (30% by 2020);• 6–10 million cases of chronic infection (in 2015) reduced to

900 000 infections (by 2030).

Mortality:• 65% reduction in chronic HBV and HCV deaths (10% by

2020);• 1.4 million annual deaths (in 2015) decreased to under

500 000 deaths (by 2030).

6 |

STI Impact Targets for 2030

Incidence and Prevention:• 90% reduction of T. pallidum incidence (2018 global

baseline);• 90% reduction in N. gonorrhoea incidence (2018 global

baseline);

• ≤50 cases of congenital syphilis per 100 000 live births in 80% of countries;

• 80% human papillomavirus vaccine coverage in adolescent 9–14 years of age in 80% of countries.

7 |

Regional Committee requested to consider:

the implications of global health sector strategies on HIV, viral hepatitis and sexually transmitted infections (2016–2021) for the WHO European Region;

how best to engage Member States, partners and relevant regional stakeholders to support implementation of global health sector strategies in the Region;

whether Regional Action plans are needed for a feasible and timely implementation of the global health sector strategies in the Region.